Li C-X, Song J, Li X, Zhang T, Li Z-M
Department of Cardiology, Qingdao Central Hospital, Qingdao, China.
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):6-8. doi: 10.26355/eurrev_202101_24308.
Correction to: European Review for Medical and Pharmacological Sciences 2020; 24 (19): 10086-10095-DOI: 10.26355/eurrev_202010_23228-PMID: 33090416, published online 15 October, 2020. After publication, the authors received a comment on PubPeer "The characterization of exosomes in this study is very limited. There is no characterization of ultrastructure (EM) and size. The anti-CD63 immunoblot does not have the typical smeared appearance and is therefore questionable. In addition, the text is full of errors and unscientific expressions". The authors thank the reader for pointing out these criticisms and specify that they re-performed some of the assays and then added the exosomes' ultrastructure with TEM. In addition, they replaced a more typical CD63 band. Spelling errors have also been corrected (in the method's section, 'lysate' was changed to 'lysis'). There are amendements to this paper. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/23228.
对《欧洲医学与药理学综述》2020年;24(19):10086 - 10095 - DOI: 10.26355/eurrev_202010_23228 - PMID: 33090416(于2020年10月15日在线发表)的更正。发表后,作者收到了PubPeer上的一条评论:“本研究中外泌体的表征非常有限。没有超微结构(电子显微镜)和大小的表征。抗CD63免疫印迹没有典型的拖尾外观,因此值得怀疑。此外,文本中充满了错误和不科学的表述”。作者感谢读者指出这些批评,并说明他们重新进行了一些检测,然后用透射电子显微镜添加了外泌体的超微结构。此外,他们替换了一个更典型的CD63条带。拼写错误也已纠正(在方法部分,‘lysate’改为‘lysis’)。本文有修订。出版商对由此可能造成的不便表示歉意。https://www.europeanreview.org/article/23228